1. Scottish Dental Clinical Effectiveness Programme. Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw: Scottish Dental Clinical Effectiveness Programme. 2017. Available online at: www.sdcep.org.uk/wp-content/uploads/2017/04/SDCEP-Oral-Health-Management-of-Patients-at-Risk-of-MRONJ-Guidance-full.pdf (Accessed February 2022).
2. American Association of Oral and Maxillofacial Surgeons. Medication-Related Osteonecrosis of the Jaw. 2014. Available online at: www.aaoms.org/docs/govt_affairs/advocacy_white_papers/mronj_position_paper.pdf (Accessed February 2022).
3. Bhanji A H. Medication related osteonecrosis of the jaws (MRONJ); Review of care at Royal Albert and Edward Infirmary (RAEI): British Association of Oral and Maxillofacial Surgeons. 2016-2017. Available online at: www.baoms.org.uk/_userfiles/pages/files/professionals/student_bursaries_2016/2016_a_bhanji_medication_related_osteonecrosis_of_the_jaws_mronj_review_of_care_at_royal_albert_and_edward_infirmary_raei.pdf (Accessed February 2022).
4. Malden N, Beltes C, Lopes V. Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm. Br Dent J 2009; 206: 93.
5. Nicolatou-Galitis O, Schiødt M, Mendes R A, Ripamonti C, Hope S, Drudge-Coates L, et al. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 2019; 127: 117-135.